Clinic
Mcallen Hospitals L P
Mcallen Hospitals L P was paid $124.61M by Medicaid between Feb 2019 and Dec 2024, across 212 billing codes. Its largest line is 99284, emergency room visit (serious) — 51% of everything it billed.
33Billing provider infoMCALLEN HOSPITALS L P
EDINBURG, TX 78539
EDINBURG, TX 78539
33aNPI1770573586assigned 10/24/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$124.61M
24GClaims1,281,299
24DCodes billed212
24AFirst – last monthFeb 2019 – Dec 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#3 of 320
Median peer was paid$205K
This provider vs. median608×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 7,743 | $277K | |
| 2020 | 43,402 | $4.04M | |
| 2021 | 259,488 | $20.77M | |
| 2022 | 404,994 | $38.79M | |
| 2023 | 381,224 | $38.90M | |
| 2024incomplete | 184,448 | $21.84M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 51% | 105,161 | 101,948 | $62.93M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 21% | 39,976 | 37,696 | $26.26M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.3% | 113,773 | 111,842 | $9.10M |
| G0378 | Hospital observation service, per hour | 2.6% | 3,945 | 3,578 | $3.23M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 44,136 | 43,332 | $2.06M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.5% | 84,312 | 42,046 | $1.89M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.1% | 3,792 | 3,603 | $1.37M |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.1% | 61,380 | 60,093 | $1.34M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.0% | 17,907 | 16,103 | $1.27M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 20,866 | 20,564 | $1.15M |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,485 | 1,989 | $1.08M |
| 71045 | Radiologic examination, chest; single view | <1% | 26,317 | 25,007 | $827K |
200 more codes
| 80053 | Comprehensive metabolic panel | <1% | 61,378 | $744K |
| 80050 | General health panel | <1% | 1,926 | $713K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 80,706 | $701K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 10,591 | $699K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 8,904 | $631K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 5,162 | $612K |
| 87430 | <1% | 26,055 | $603K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 2,456 | $452K |
| 87507 | <1% | 749 | $409K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,224 | $340K |
| 87070 | <1% | 26,676 | $309K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 2,033 | $260K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,946 | $258K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 4,696 | $253K |
| 81025 | <1% | 22,353 | $249K | |
| 74018 | <1% | 5,251 | $245K | |
| 76801 | <1% | 2,054 | $240K | |
| 81001 | <1% | 61,582 | $236K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 4,173 | $216K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,888 | $212K |
| 83690 | <1% | 20,336 | $161K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,564 | $146K |
| 84484 | <1% | 17,695 | $144K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,141 | $138K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,441 | $137K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 406 | $134K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 818 | $109K |
| 87420 | <1% | 5,077 | $103K | |
| 87040 | <1% | 9,211 | $103K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,751 | $101K |
| 83880 | <1% | 5,119 | $100K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 242 | $82K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 18,030 | $75K |
| 84702 | <1% | 4,579 | $72K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 456 | $61K |
| 76775 | <1% | 559 | $59K | |
| 86850 | <1% | 1,556 | $58K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 728 | $56K |
| 12001 | <1% | 180 | $55K | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | <1% | 1,441 | $52K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 859 | $51K |
| 74022 | <1% | 699 | $50K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,338 | $49K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 344 | $49K |
| 80061 | Lipid panel | <1% | 3,870 | $48K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,363 | $47K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,202 | $46K |
| 73610 | <1% | 874 | $42K | |
| 74019 | <1% | 720 | $42K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 15 | $41K |
| 83605 | <1% | 4,100 | $39K | |
| 86140 | <1% | 5,972 | $38K | |
| 73630 | <1% | 900 | $38K | |
| 73130 | <1% | 809 | $37K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 990 | $36K |
| 85730 | <1% | 9,284 | $35K | |
| 73564 | <1% | 773 | $32K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,162 | $31K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,223 | $28K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 260 | $28K |
| 85610 | <1% | 10,092 | $28K | |
| 72100 | <1% | 755 | $27K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 576 | $26K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,023 | $24K |
| 70486 | <1% | 242 | $24K | |
| 83735 | <1% | 5,506 | $24K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 549 | $23K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 588 | $23K |
| 82550 | <1% | 4,295 | $23K | |
| 59025 | Fetal non-stress test | <1% | 171 | $22K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 165 | $21K |
| 90715 | <1% | 619 | $21K | |
| 73030 | <1% | 677 | $20K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 37 | $19K |
| 81003 | <1% | 7,354 | $19K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,601 | $19K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 14,907 | $19K |
| 82607 | <1% | 907 | $18K | |
| 73110 | <1% | 364 | $18K | |
| 82746 | <1% | 902 | $18K | |
| 87186 | <1% | 2,997 | $18K | |
| 76770 | <1% | 91 | $17K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 5,360 | $17K |
| 87077 | <1% | 3,082 | $17K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 100 | $16K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 569 | $16K |
| 36415 | Collection of venous blood by venipuncture | <1% | 99,301 | $16K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 26 | $16K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 252 | $15K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,081 | $15K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 260 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,745 | $14K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 219 | $13K |
| 85027 | <1% | 2,316 | $13K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,578 | $13K |
| 83520 | <1% | 523 | $13K | |
| 73090 | <1% | 398 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,753 | $13K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 24,698 | $12K |
| 87581 | <1% | 406 | $12K | |
| 87486 | <1% | 406 | $12K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,245 | $10K |
| 80076 | <1% | 1,049 | $10K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 987 | $10K |
| 82803 | <1% | 430 | $8K | |
| 85379 | <1% | 997 | $8K | |
| 72040 | <1% | 166 | $7K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 26 | $7K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 952 | $6K |
| 72170 | <1% | 365 | $6K | |
| 93971 | <1% | 78 | $6K | |
| 86900 | <1% | 2,733 | $6K | |
| 86901 | <1% | 2,732 | $6K | |
| 82150 | <1% | 958 | $6K | |
| 73590 | <1% | 181 | $6K | |
| 90714 | <1% | 231 | $6K | |
| 73080 | <1% | 152 | $6K | |
| 82140 | <1% | 594 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,284 | $5K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 215 | $4K |
| 12011 | <1% | 14 | $4K | |
| 82784 | <1% | 260 | $3K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 288 | $3K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,146 | $3K |
| 86738 | <1% | 197 | $3K | |
| 86317 | <1% | 154 | $3K | |
| 86003 | <1% | 81 | $3K | |
| 84146 | <1% | 120 | $3K | |
| 74230 | <1% | 12 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,166 | $3K |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 47 | $3K |
| 76641 | <1% | 26 | $3K | |
| 87184 | <1% | 323 | $3K | |
| 71250 | <1% | 52 | $3K | |
| 87205 | <1% | 841 | $2K | |
| 36600 | <1% | 75 | $2K | |
| 84436 | <1% | 424 | $2K | |
| 82785 | <1% | 104 | $2K | |
| 87075 | <1% | 327 | $2K | |
| 70260 | <1% | 32 | $2K | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 827 | $2K |
| 83883 | <1% | 118 | $2K | |
| 93970 | <1% | 13 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 89 | $2K |
| 84439 | <1% | 252 | $2K | |
| 85652 | <1% | 667 | $2K | |
| 85007 | <1% | 353 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $2K |
| 83525 | <1% | 80 | $1K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 204 | $1K |
| 73140 | <1% | 30 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 13 | $1K |
| 86141 | <1% | 67 | $1K | |
| 82787 | <1% | 117 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $1K |
| J2470 | Injection, pantoprazole sodium, 40 mg | <1% | 60 | $1K |
| 84100 | <1% | 351 | $995.20 | |
| 82570 | <1% | 124 | $975.69 | |
| 88304 | <1% | 14 | $893.94 | |
| 84480 | <1% | 39 | $799.35 | |
| 92611 | <1% | 12 | $631.95 | |
| 84145 | <1% | 164 | $598.18 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 12 | $590.14 |
| 84156 | <1% | 92 | $570.39 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 93 | $519.28 |
| 84132 | <1% | 178 | $516.06 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 16 | $504.51 |
| 87641 | <1% | 30 | $502.74 | |
| 73060 | <1% | 26 | $488.17 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 2,418 | $459.14 |
| 96376 | <1% | 427 | $442.71 | |
| 84479 | <1% | 80 | $428.81 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 114 | $412.69 |
| 90686 | <1% | 66 | $392.73 | |
| 82947 | <1% | 68 | $389.73 | |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 121 | $348.57 |
| 82962 | <1% | 7,943 | $345.27 | |
| 82270 | <1% | 82 | $239.88 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 112 | $230.59 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,518 | $221.78 |
| J1920 | Injection, labetalol hydrochloride, 5 mg | <1% | 13 | $196.26 |
| 85018 | <1% | 126 | $176.38 | |
| 82010 | <1% | 12 | $123.20 | |
| 77080 | <1% | 13 | $70.55 | |
| A9270 | Non-covered item or service | <1% | 5,021 | $61.68 |
| 82565 | <1% | 41 | $59.97 | |
| J0456 | Injection, azithromycin, 500 mg | <1% | 12 | $53.40 |
| 85014 | <1% | 37 | $39.03 | |
| 82043 | <1% | 39 | $37.20 | |
| 84520 | <1% | 26 | $30.74 | |
| G0008 | Administration of influenza virus vaccine | <1% | 15 | $27.21 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 244 | $21.79 |
| 84550 | <1% | 14 | $19.30 | |
| C1769 | Guide wire | 0% | 12 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 28 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 12 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 26 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 50 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 13 | $0.00 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (CFO, SENIOR VP)
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
| Friends Behavioral Health System, LP | Philadelphia, PA | $9.55M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.